Subtle Medical Gains FDA Clearance for SubtleHD PET
MENLO PARK, Calif., May 27, 2026 Subtle Medical, a leading developer of AI-powered medical imaging software, has announced that...
Alzheimer’s Disease
Advertisement
Creative Medical Technology Pioneers Regenerative Immunotherapy with AI-Enhanced Cell Platforms
Phoenix, AZ – October 27, 2025: Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company, has issued...
Sanofi Q3 2025 Results: Strong Growth and Key Approvals
PARIS – October 24, 2025 Sanofi reported a 7.0% sales increase at constant exchange rates (CER) for Q3 2025,...
FDA Approves LEQEMBI IQLIK Subcutaneous Autoinjector for Maintenance Dosing in Early Alzheimer’s Disease
Eisai Co., Ltd. and Biogen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved LEQEMBI®...
Advertisement
